RFK Jr. & claimed regenerative peptides like BPC 157 The Niche FDA Moves to Reevaluate Several Peptides American Med Spa Association Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica